In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Photomedex Inc (NASDAQ:PHMD) reported that Pell Lewis C has picked up 424,064 of common stock as of 2017-05-01. The acquisition brings the aggregate amount owned by Pell Lewis C to a total of 424,064 representing...
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), International Isotopes Inc. (OTCBB:INIS) reported that Kennerman Associates, Inc. has picked up 195,304,771 of common stock as of 2017-05-01. The acquisition brings the aggregate amount owned by Kennerman Associates, Inc. to a total of 195,304,771 representing...
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Onconova Therapeutics Inc. (NASDAQ:ONTX) reported that Sabby Capital has picked up 702,896 of common stock as of 2017-05-01. The acquisition brings the aggregate amount owned by Sabby Capital to a total of 702,896 representing less than...
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Arena Pharmaceuticals Inc (NASDAQ:ARNA) reported that Great Point Partners has picked up 30,000,000 of common stock as of 2017-04-28. The acquisition brings the aggregate amount owned by Great Point Partners to a total of 30,000,000 representing...
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC),Incyte Corp (NASDAQ:INCY) reported that Baker Bros. Advisors has picked up 34,295,011 of common stock as of 2017-04-28. The acquisition brings the aggregate amount owned by Baker Bros. Advisors to a total of 34,295,011 representing less...
CytRx Corporation (NASDAQ:CYTR) shares were down 15.02% on Thursday to $0.685 and an additional 7.65% in after-hours trading to $0.632. The company has a market cap of $75.70 million at 117.32 million shares outstanding. Share prices have been trading in a 52-week range of $0.36 to $3.46. CytRx Corporation is a...
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Ptc Therapeutics Inc. (NASDAQ:PTCT) reported that Complete Pharma Holdings Ii, Llc. has picked up 6,683,598 of common stock as of 2017-04-27. The acquisition brings the aggregate amount owned by Complete Pharma Holdings Ii, Llc. to a...
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Oncomed Pharmaceuticals Inc (NASDAQ:OMED) reported that Biotechnology Value Fund L P has picked up 1,372,923 of common stock as of 2017-04-27. The acquisition brings the aggregate amount owned byBiotechnology Value Fund L P to a total...
NanoViricides Inc (NYSEMKT:NNVC) shares dipped 2.61% on Wednesday to $1.12 and were unchanged in after-hours trading. Share prices have been trading in a 52-week range of $1.03 to $2.18. The company has a market cap of $72.89 million at 62.82 million shares outstanding. NanoViricides Inc is a nano-biopharmaceutical company with several drugs...
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Audentes Therapeutics Inc. (NASDAQ:BOLD) reported that Flynn James E  has picked up 1,214,423 of common stock as of 2017-04-26. The acquisition brings the aggregate amount owned by Flynn James E to a total of 1,214,423...